Indian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...

Quality stocks in India and globally are at their cheapest in years. Saurabh Mukherjea highlights export-oriented manufacturing, European a...

US trade representative Jamieson Greer will visit India on June 23-24. He will meet Commerce and Industry Minister Piyush Goyal. Discussion...

India is actively pursuing Free Trade Agreements to boost market access and shield its businesses. These agreements target complementary ec...

US export controls on advanced AI models have spurred India's call for sovereign AI development. Industry leaders warn against reliance on ...

A US ban on advanced AI models has highlighted the vulnerability of foreign reliance, according to Sarvam AI's Pratyush Kumar. He urged Ind...

India has built a strong foundation for growth over the past decade, according to Vikas Khemani of Carnelian Asset Management. He highlight...

In a landmark agreement, India is teaming up with the UAE to significantly increase its oil reserves, transitioning into a strategic player...

India is pushing back against US allegations of excess production capacity in textiles and steel. Government officials argue that domestic ...

India may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...

With AI investments taking center stage, South Korea and Taiwan's stock markets have outpaced India in terms of market capitalisation, larg...

He announced plans for an aquaculture corridor to integrate research and technology, aiming to position Andhra Pradesh as a sector growth h...

He believes a combination of free trade agreements (FTAs), a weakening rupee, and shifting global supply chains could create a massive oppo...

India 12.5% new tariff: Indian exporters are watching US tariff reviews closely, hoping that trade talks will protect their market share. A...

The Indian rupee is dipping to historic lows, approaching the 100-dollar threshold. Driven by market sentiment and a perilous cycle of fore...

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...

Ajay Bagga offers a clear strategy for Indian markets. He advises waiting for real AI revenue in IT. Pharma remains a strong investment due...